« Back to Members

HAS Healthcare Advanced Synthesis SA

HAS Healthcare Advanced Synthesis SA

HAS Healthcare Advanced Synthesis offers a full range of customized services for our clients – from lab development, to manufacturing, to regulatory and approval and beyond, specializing in high potency substances.

We develop and manufacture Active Pharmaceutical Ingredients (APIs), cGMP Advanced Intermediates, High Potency APIs (HPAPIs) and Anticancer compounds for our clients from clinical to commercial supply, on an exclusive basis.

At HAS Healthcare Advanced Synthesis we’re passionate about tailoring our services to our clients’ clinical and commercial manufacturing needs and going the extra mile to support them with their analytical and regulatory requirements. We specialize in the delivery of oncology and rare disease compounds and hold a strong track record in reducing time to market for life saving products in these areas.

Via Industria 24
6710 Biasca
T.: +41 91 873 94 00
F.: +41 91 873 01 11
https://www.hashealthcare.com/
info@hashealthcare.com

  • Main activities
    Co-development
    Drug Substance CMO
    Other CMO Activities

  • Drug stages
    Phase I - Phase III
    Registration
    Market
    Generic
    Life cycle management

  • Therapeutic areas
    Cancer supportive therapy
    CNS
    Dermatology
    Gastrointestinal
    Gynaecology
    Oncology
    Ophtalmology
    Respiratory
    Other

  • Markets
    CH
    EU Top 5
    Rest of Europe
    USA and Canada
    LATAM
    Japan

  • Drug substance type
    APIs (1-10kgs/batch)
    APIs (20-200kgs/batch)
    APIs (>200kgs/batch)
    HPAI 10-100g/batch
    HPAI 0.2-5kgs/batch
    HPAI 6-20kgs/batch
    HPAI >20kgs/batch
    HPAI Cat. 3 safebridge
    Cytotoxics

  • Other CMO activities
    Micronization